ZEPP vs AAPL

For growth investors, Apple Inc.

(AAPL) is the stronger pick with 6. 4% revenue growth year-over-year, versus -46. 6% for Zepp Health Corporation (ZEPP). Apple Inc. (AAPL) offers the better valuation at 38. 5x trailing P/E (33. 8x forward), making it the more compelling value choice. Analysts rate Apple Inc. (AAPL) a "Buy" — based on 110 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Apple Inc.

is actually cheaper at 33. 8x.

Over the past 5 years, Apple Inc.

(AAPL) delivered a total return of +124. 4%, compared to -60. 7% for Zepp Health Corporation (ZEPP). Over 10 years, the gap is even starker: AAPL returned +1174% versus ZEPP's -66. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Apple Inc.

(AAPL) is the lower-risk stock at 0. 99β versus Zepp Health Corporation's 1. 63β — meaning ZEPP is approximately 66% more volatile than AAPL relative to the S&P 500. On balance sheet safety, Zepp Health Corporation (ZEPP) carries a lower debt/equity ratio of 72% versus 152% for Apple Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Apple Inc.

(AAPL) is pulling ahead at 6. 4% versus -46. 6% for Zepp Health Corporation (ZEPP). On earnings-per-share growth, the picture is similar: Apple Inc. grew EPS 22. 7% year-over-year, compared to -1642. 9% for Zepp Health Corporation. Over a 3-year CAGR, AAPL leads at 1. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Apple Inc.

(AAPL) is the more profitable company, earning 26. 9% net margin versus -41. 6% for Zepp Health Corporation — meaning it keeps 26. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AAPL leads at 32. 0% versus -25. 9% for ZEPP. At the gross margin level — before operating expenses — AAPL leads at 46. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Apple Inc.

(AAPL) trades at 33. 8x forward P/E versus 213. 9x for Zepp Health Corporation — 180. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AAPL: 10. 3% to $317. 11.

In this comparison, AAPL (0.

4% yield) pays a dividend. ZEPP does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Apple Inc.

(AAPL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 99), +1174% 10Y return). Zepp Health Corporation (ZEPP) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AAPL: +1174%, ZEPP: -66. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.